NewEdge Wealth LLC Purchases Shares of 51,884 FT Vest U.S. Equity Deep Buffer ETF October (BATS:DOCT)

NewEdge Wealth LLC purchased a new stake in FT Vest U.S. Equity Deep Buffer ETF October (BATS:DOCT) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 51,884 shares of the company’s stock, valued at approximately $1,886,000. NewEdge Wealth LLC owned approximately 1.10% of FT Vest U.S. Equity Deep Buffer ETF October at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV acquired a new stake in shares of FT Vest U.S. Equity Deep Buffer ETF October during the fourth quarter worth about $34,000. Sunbelt Securities Inc. acquired a new stake in shares of FT Vest U.S. Equity Deep Buffer ETF October during the first quarter worth about $100,000. Presidio Capital Management LLC purchased a new position in shares of FT Vest U.S. Equity Deep Buffer ETF October during the fourth quarter worth about $216,000. NBC Securities Inc. purchased a new position in shares of FT Vest U.S. Equity Deep Buffer ETF October during the third quarter worth about $218,000. Finally, Strategic Blueprint LLC grew its holdings in shares of FT Vest U.S. Equity Deep Buffer ETF October by 20.9% during the third quarter. Strategic Blueprint LLC now owns 7,592 shares of the company’s stock worth $263,000 after buying an additional 1,313 shares during the last quarter.

FT Vest U.S. Equity Deep Buffer ETF October Stock Performance

BATS DOCT opened at $37.44 on Monday. The business’s 50-day moving average is $37.34 and its 200-day moving average is $36.22. The stock has a market capitalization of $175.97 million, a price-to-earnings ratio of 18.42 and a beta of 0.33.

FT Vest U.S. Equity Deep Buffer ETF October Company Profile

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.